ANTIMITOCHONDRIAL ANTIBODY - ANVISA Registration 10300390662
Access comprehensive regulatory information for ANTIMITOCHONDRIAL ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10300390662 and manufactured by ORGENTEC DIAGNOSTIKA GMBH. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including INOVA DIAGNOSTICS, INC., PHADIA AB, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
10300390662
25351250684201958
00904728000148
Company Information
Dates and Status
May 20, 2019
VIGENTE
09/18/2025 19:00:01
ANTICORPO ANTIMITOCONDRIAL
AESKUSLIDES rLKS
AESKU DIAGNOSTICS GMBH & CO. KG
82910510001
Mar 05, 2025
ANTICORPO ANTIMITOCONDRIAL
FAMรLIA MAGLUMIยฎ AMA-M2 IgG (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790432
Sep 16, 2024
ANTICORPO ANTIMITOCONDRIAL
HepAK 7plus Dot
GA GENERIC ASSAYS GMBH
80464810897
Mar 04, 2024
ANTICORPO ANTIMITOCONDRIAL
Famรญlia QUANTA Flash M2 (MIT3)
INOVA DIAGNOSTICS, INC.
80003610581
Aug 10, 2020
ANTICORPO ANTIMITOCONDRIAL
MAGLUMI IgG Anti-M2-3E (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512408
Mar 02, 2020

